Gemcitabine in combination with capecitabine in metastatic breast carcinoma: A phase I-II study.

被引：0
|
作者：
Giannessi, PG [1 ]
Martella, F [1 ]
Di Marsico, R [1 ]
Coltelli, L [1 ]
Safina, V [1 ]
Andreuccetti, M [1 ]
Falcone, A [1 ]
机构：
[1] UO Oncol Med, Livorno, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：95S / 95S
页数：1
相关论文
共 50 条
  • [41] Phase I-II study of the weekly administration of a docetaxel and vinorelbine combination in metastatic breast cancer (MBC) patients.
    Cals, L
    Nouyrigat, P
    Merad, L
    Laadem, A
    Berchoff, V
    Pedinielli, FJ
    Valenza, B
    Tchiknavorian, X
    Juin, P
    ANNALS OF ONCOLOGY, 2000, 11 : 39 - 40
  • [42] Efficacy of sorafenib in combination with gemcitabine and fluorouracil in metastatic renal-cell carcinoma: Preliminary result of a multicenter phase II study.
    Guo, J.
    Cui, C. L.
    Chen, H.
    Xie, X. D.
    Chen, J.
    Liang, J.
    Li, F.
    Liu, T. S.
    Chi, Z. H.
    Si, L.
    Sheng, X. N.
    Li, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [43] Oral combination chemotherapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: a phase II study
    Tanaka, Maki
    Takamatsu, Yasushi
    Anan, Keisei
    Ohno, Shinji
    Nishimura, Reiki
    Yamamoto, Yutaka
    Masuda, Norikazu
    Mitsuyama, Shoshu
    Tamura, Kazuo
    ANTI-CANCER DRUGS, 2010, 21 (04) : 453 - 458
  • [44] Weekly docetaxel in pretreated metastatic breast cancer patients:: A phase I-II study
    Nisticò, C
    Cognetti, F
    Frontini, L
    Barni, S
    Ferretti, G
    Bria, E
    Milella, M
    Garufi, C
    Cuppone, F
    Vanni, B
    Carlini, P
    Terzoli, E
    ONCOLOGY, 2005, 68 (4-6) : 356 - 363
  • [45] Phase I study of capecitabine in combination with paclitaxel in patients with previously treated metastatic breast cancer
    Villalona-Calero, M
    Blum, J
    Diab, S
    Elledge, R
    Khoury, P
    Kraynak, M
    Moczygemba, J
    Kromelis, P
    Impellizeri, K
    Griffin, T
    Von Hoff, D
    Rowinsky, E
    ANNALS OF ONCOLOGY, 1998, 9 : 97 - 97
  • [46] Phase II study of capecitabine and gemcitabine in patients with metastatic colorectal cancer (mCRC)
    Iqbal, S.
    Yang, D.
    Cole, S.
    El-Khoueiry, A. B.
    Boswell, W.
    Agafitei, R.
    Lujan, R.
    Lenz, H. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [47] A Phase I-II Trial of Dasatinib (D) in Combination with Weekly (w) Paclitaxel (P) for Patients (Pts) with Metastatic Breast Carcinoma (MBC)
    Morris, P. G.
    Abbruzzi, A.
    D'Andrea, G.
    Gilewski, T.
    Lake, D.
    Bromberg, J.
    Dang, C.
    Dickler, M.
    Modi, S.
    Seidman, A. D.
    Sklarin, N.
    Chang, J.
    Patil, S.
    Norton, L.
    Hudis, C. A.
    Fornier, M. N.
    CANCER RESEARCH, 2010, 70
  • [48] Phase II study of a gemcitabine and cisplatin combination regimen in taxane resistant metastatic breast cancer
    Seo, Jae Hong
    Oh, Sang Cheul
    Choi, Cheul Won
    Kim, Byung Soo
    Shin, Sang Won
    Kim, Yeul Hong
    Kim, Jun Suk
    Kim, Ae-Ree
    Lee, Jae-Bok
    Koo, Bum Hwan
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (02) : 269 - 274
  • [49] A phase II trial of a combination of pemetrexed and gemcitabine in patients with metastatic breast cancer: an NCCTG study
    Ma, CX
    Steen, P
    Rowland, KM
    Niedringhaus, RD
    Fitch, TR
    Kugler, JW
    Hillman, DW
    Perez, EA
    Ingle, JN
    Adjei, AA
    ANNALS OF ONCOLOGY, 2006, 17 (02) : 226 - 231
  • [50] Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer
    Rivera, E
    Valero, V
    Arun, B
    Royce, M
    Adinin, R
    Hoelzer, K
    Walters, R
    Wade, JL
    Pusztai, L
    Hortobagyi, GN
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (17) : 3249 - 3254
12345